应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
SILO SILO PHARMA INC.
盘后交易 10-20 19:24:58 EDT
1.20
+0.07
+6.19%
盘后
1.14
-0.06
-5.00%
16:25 EDT
最高
1.21
最低
1.15
成交量
9,512
今开
1.15
昨收
1.13
日振幅
5.41%
总市值
190.60万
流通市值
182.82万
总股本
158.83万
成交额
1.13万
换手率
0.62%
流通股本
152.35万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Silo Pharma与Parkview Consulting签署资产购买协议，2026年8月18日SEC文件披露
美股速递 · 08-20
Silo Pharma与Parkview Consulting签署资产购买协议，2026年8月18日SEC文件披露
Silo Pharma：根据SEC文件，出售股东以转售方式提供190万股Silo Pharma普通股
美股速递 · 07-25
Silo Pharma：根据SEC文件，出售股东以转售方式提供190万股Silo Pharma普通股
Silo Pharma子公司Qwikagents拟通过英伟达开发者计划推进企业AI智能体平台发展
美股速递 · 07-07
Silo Pharma子公司Qwikagents拟通过英伟达开发者计划推进企业AI智能体平台发展
Silo Pharma 开展稳健性研究，评估 SPC-15 设备性能与制剂 30 天稳定性
美股速递 · 06-30
Silo Pharma 开展稳健性研究，评估 SPC-15 设备性能与制剂 30 天稳定性
Silo Pharma公布SPC-15创伤后应激障碍治疗药物稳定性数据积极，推动项目迈向首次人体临床试验
美股速递 · 06-23
Silo Pharma公布SPC-15创伤后应激障碍治疗药物稳定性数据积极，推动项目迈向首次人体临床试验
Silo Pharma旗下Demerx NB获FDA新药临床试验批准 诺伊波加因靶向酒精使用障碍治疗
美股速递 · 04-29
Silo Pharma旗下Demerx NB获FDA新药临床试验批准 诺伊波加因靶向酒精使用障碍治疗
Silo Pharma, Inc.盘中异动 股价大跌5.46%报1.28美元
市场透视 · 2025-03-03
Silo Pharma, Inc.盘中异动 股价大跌5.46%报1.28美元
Silo Pharma, Inc.盘中异动 股价大跌5.67%
市场透视 · 2025-02-27
Silo Pharma, Inc.盘中异动 股价大跌5.67%
Silo Pharma, Inc.盘中异动 快速上涨5.40%报1.47美元
市场透视 · 2025-02-27
Silo Pharma, Inc.盘中异动 快速上涨5.40%报1.47美元
Silo Pharma, Inc.盘中异动 急速拉升5.56%报1.38美元
市场透视 · 2025-02-26
Silo Pharma, Inc.盘中异动 急速拉升5.56%报1.38美元
Silo Pharma, Inc.盘中异动 早盘股价大跌5.19%报1.28美元
市场透视 · 2025-02-24
Silo Pharma, Inc.盘中异动 早盘股价大跌5.19%报1.28美元
Silo Pharma, Inc.盘中异动 下午盘急速下跌5.03%报1.42美元
市场透视 · 2025-02-22
Silo Pharma, Inc.盘中异动 下午盘急速下跌5.03%报1.42美元
Silo Pharma, Inc.盘中异动 快速拉升5.00%报1.47美元
市场透视 · 2025-02-20
Silo Pharma, Inc.盘中异动 快速拉升5.00%报1.47美元
Silo Pharma, Inc.盘中异动 早盘大幅下跌5.19%
市场透视 · 2025-02-11
Silo Pharma, Inc.盘中异动 早盘大幅下跌5.19%
Silo Pharma, Inc.盘中异动 早盘快速拉升5.68%报1.82美元
市场透视 · 2025-02-06
Silo Pharma, Inc.盘中异动 早盘快速拉升5.68%报1.82美元
Silo Pharma, Inc.盘中异动 股价大跌5.02%
市场透视 · 2025-02-04
Silo Pharma, Inc.盘中异动 股价大跌5.02%
Silo Pharma, Inc.盘中异动 大幅上涨11.19%报1.79美元
市场透视 · 2025-02-03
Silo Pharma, Inc.盘中异动 大幅上涨11.19%报1.79美元
Silo Pharma, Inc.盘中异动 大幅跳水5.46%
市场透视 · 2025-02-01
Silo Pharma, Inc.盘中异动 大幅跳水5.46%
Silo Pharma, Inc.盘中异动 下午盘大幅下跌5.07%
市场透视 · 2025-01-28
Silo Pharma, Inc.盘中异动 下午盘大幅下跌5.07%
Silo Pharma, Inc.盘中异动 股价大涨5.61%
市场透视 · 2025-01-24
Silo Pharma, Inc.盘中异动 股价大涨5.61%
加载更多
公司概况
公司名称：
SILO PHARMA INC.
所属市场：
NASDAQ
上市日期：
--
主营业务：
Silo Pharma, Inc.于2010年7月13日在纽约州注册成立。2013年1月24日，公司将其注册地从纽约州改为特拉华州。2023年12月19日，该公司将其注册州从特拉华州改为内华达州。该公司是一家处于开发阶段的生物制药和加密货币公司，专注于开发针对创伤后应激障碍、应激性焦虑症、纤维肌痛和中枢神经系统疾病等未满足需求的新型疗法。其主要项目SPC-15是一种用于治疗创伤后应激障碍和应激性焦虑症的鼻内候选药物。
发行价格：
--
{"stockData":{"symbol":"SILO","market":"US","secType":"STK","nameCN":"SILO PHARMA INC.","latestPrice":1.2,"timestamp":1792526400000,"preClose":1.13,"halted":0,"volume":9512,"hourTrading":{"tag":"盘后","latestPrice":1.14,"preClose":1.2,"latestTime":"16:25 EDT","volume":423,"amount":489.91618889999995,"timestamp":1792527908940,"change":-0.06,"changeRate":-0.05,"amplitude":0.05},"delay":0,"changeRate":0.06194690265486732,"floatShares":1523502,"shares":1588300,"eps":-5.066727,"marketStatus":"盘后交易","change":0.07,"latestTime":"10-20 19:24:58 EDT","open":1.1514,"high":1.2099,"low":1.1488,"amount":11274,"amplitude":0.054071,"askPrice":1.24,"askSize":22,"bidPrice":1.18,"bidSize":128,"shortable":3,"etf":0,"ttmEps":-5.066727,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1792540800000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":1.13,"preHourTrading":{"tag":"盘前","latestPrice":1.17,"preClose":1.13,"latestTime":"08:02 EDT","volume":2,"amount":2.34,"timestamp":1792497767369,"change":0.04,"changeRate":0.035398,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.14,"preClose":1.2,"latestTime":"16:25 EDT","volume":423,"amount":489.91618889999995,"timestamp":1792527908940,"change":-0.06,"changeRate":-0.05,"amplitude":0.05},"volumeRatio":0.180613},"requestUrl":"/m/hq/s/SILO","defaultTab":"news","newsList":[{"id":"1125334791","title":"Silo Pharma与Parkview Consulting签署资产购买协议，2026年8月18日SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1125334791","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125334791?lang=zh_cn&edition=full","pubTime":"2026-08-20 05:19","pubTimestamp":1787174351,"startTime":"0","endTime":"0","summary":"Silo Pharma于2026年8月18日与Parkview Consulting达成资产购买协议。此消息源自公司向美国证券交易委员会（SEC）提交的官方文件。\n这一战略举措标志着Silo Pharma在业务布局上的重要一步。协议签署的细节已在监管文件中完整呈现。\n市场参与者对此交易的反应尚待观察。Silo Pharma的这一决策，可能预示着公司在资产组合优化方面的新动向。SEC文件为该协议的条款提供了正式记录，确保交易的透明度。\n截至发稿时，Silo Pharma尚未就协议的具体财务条款和涉及的资产类别发表进一步评论。此次合作或将影响公司未来的发展方向，值得持续关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4202","SILO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168075273","title":"Silo Pharma：根据SEC文件，出售股东以转售方式提供190万股Silo Pharma普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1168075273","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168075273?lang=zh_cn&edition=full","pubTime":"2026-07-25 04:08","pubTimestamp":1784923689,"startTime":"0","endTime":"0","summary":"Silo Pharma（SILO）传来最新消息——据美国证券交易委员会（SEC）披露的文件显示，该公司的出售股东正计划以转售方式，将高达190万股Silo Pharma普通股推向市场。这一动作并非由公司直接增发，而是现有股东在特定条件下进行股份转让或流通。这一规模不容小觑，可能对市场供需格局产生一定影响。交易细节与背景仍需投资者持续关注，以评估后续的市场反应与股价走向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4202","BK4139","SILO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142669587","title":"Silo Pharma子公司Qwikagents拟通过英伟达开发者计划推进企业AI智能体平台发展","url":"https://stock-news.laohu8.com/highlight/detail?id=1142669587","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142669587?lang=zh_cn&edition=full","pubTime":"2026-07-07 20:16","pubTimestamp":1783426561,"startTime":"0","endTime":"0","summary":"Silo Pharma旗下子公司Qwikagents正着手通过参与英伟达开发者计划，以加速其企业级人工智能智能体平台的研发进程。此举旨在利用英伟达先进的硬件与软件生态系统，赋能其AI解决方案，从而在竞争激烈的企业服务市场中占据更有利的技术高地。通过接入该计划，Qwikagents将能够更深入地整合英伟达的计算平台与开发工具，这有望显著提升其AI智能体在处理复杂企业任务时的性能与效率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0511384066.AUD","2NVD.UK","LU0274383776.USD","LU1400636574.HKD","LU2637965513.SGD","LU0557290698.USD","LU0289960550.SGD","HK0000532082.HKD","LU0823434583.USD","LU0029864427.USD","LU0345768153.USD","IE00BKPKM429.USD","LU2089985449.USD","LU2249611893.SGD","LU1880398471.USD","LU0979878070.USD","LU2322448957.HKD","IE00B3SWFQ91.USD","LU0868494617.USD","SG9999001424.SGD","BK4549","IE00BQXX3F31.USD","LU2108987350.USD","LU1935042991.SGD","LU2456880835.USD","LU2168564065.EUR","SG9999015341.SGD","LU1983260115.SGD","LU0080751232.USD","LU1720051108.HKD","LU1037948897.HKD","LU2077746001.SGD","LU2237443622.USD","LU0861579265.USD","NVD","SG9999014542.SGD","LU0316494557.USD","LU0289961442.SGD","LU1791710582.SGD","LU0310799852.SGD","LU0494093205.USD","LU1974910355.USD","LU0006306889.USD","IE00BJJMRX11.SGD","LU0965509010.AUD","LU2286300806.USD","LU0094547139.USD","NVDB","NVD2.UK","SHOC","NVDQ","LU0957808578.USD","LU1633808545.USD","LU2756315318.SGD","LU0882574139.USD","LU0466842654.USD","ANV","SG9999014914.USD","LU1674673691.USD","LU2394011477.USD","LU1551013342.USD","LU2458330169.SGD","BK4550","LU0124676726.USD","SG9999014575.USD","LU1914381329.SGD","LU0158827781.USD","TYLG","LU1992135472.HKD","CLSE","LU0719512351.SGD","LU1119994496.HKD","NVIW.SI","LU2097344357.USD","LU2491050154.USD","BK4543","IE0004086264.USD","LU2505996509.AUD","SGXZ23171101.USD","BK4527","LU1066051498.USD","LU1917777945.USD","LU2471134879.HKD","LU0289739343.SGD","LU0323240290.USD","LU2360106780.USD","LU0210533765.USD","IXN","LU0345770308.USD","LU2028103732.USD","LU2462157665.USD","NVDS.UK","LU1244550494.USD","LU0157215616.USD","DIPS","IE0003U64NQ7.SGD","NVDL","LU2125909593.SGD","LU0081259029.USD","HK0000819398.USD","LU0256863902.USD","LU1066051225.USD","IE00BJTD4N35.SGD","IE00BYXW3230.USD","BK4533","LU2247934214.USD","LU0957791311.USD","IE0004445015.USD","LU1815336760.USD","LU1366333091.USD","IE0034235295.USD","LU1778281490.HKD","BK4551","LU1868837300.USD","VGT","LU0127658192.USD","LU1366192091.USD","LU0320765059.SGD","IE00BHPRN162.USD","SG9999018865.SGD","LU2242649171.HKD","LU2360032135.SGD","LU0823434740.USD","LU2433249047.HKD","LU0048584097.USD","LU2265009873.SGD","HK0000320264.USD","LU2999663052.SGD","LU0345768740.USD","LU2746668974.SGD","LU1861220033.SGD","SNPE","IE00BQXX3D17.EUR","LU0143551892.USD","IE00B3M56506.USD","LU2750360997.AUD","LU0943347566.SGD","LU1571399168.USD","LU0820562030.AUD","LU2360107168.USD","LU3102509885.SGD","LU0689626769.HKD","SILO","LU2125909247.SGD","LU1868837136.USD","SOXQ","ABFL","LU0109392836.USD","LU2065169927.USD","LU0345769631.USD","LU0444973449.USD","BK4141","SG9999014906.USD","IE00B7KXQ091.USD","LU0128525929.USD","LU0053666078.USD","LU2471134952.CNY","HK0000306701.USD","LU1814569148.SGD","SG9999014567.USD","LU0175139822.USD","LU0158827948.USD","LU2272731782.SGD","BK4598","NVDU","IE00BK4W5L77.USD","HK0000914686.HKD","LU2326559502.SGD","LU0323591593.USD","LU0210528500.USD","BK4548","LU2403377893.USD","LU0082616367.USD","LU2065171311.SGD","IE00BZ199S13.USD","LU1951198990.SGD","BK4534","IE0009G5SDU7.USD","SG9999000418.SGD","FDTX","NVD3.UK","IE00B19Z8X17.USD","LU1803068979.SGD","LU2089283258.USD","LU1496350502.SGD","LU2242650005.HKD","FTEC","LU2023250504.SGD","LU2491049909.HKD","LU1934455277.USD","LU2491050071.SGD","NVDO","LU1699723380.USD","TTEQ","IE00B775SV38.USD","LU1145028129.USD","LU0642271901.SGD","LU1066051811.HKD","LU2092937148.SGD","LU0820561909.HKD","LU0276348264.USD","IE00BDRTCR15.USD","LU1988902786.USD","BK4588","LU2430703251.USD","LU2063271972.USD","LU1923623000.USD","LU2462591350.SGD","LU1548497426.USD","LU0011850046.USD","BK4608","CNEQ","3NVD.UK","LU0056508442.USD","LU0154236417.USD","LU1642822529.SGD","LU2471134523.USD","LU2087625088.SGD","LU1935042488.USD","LU2125909916.SGD","SG9999017495.SGD","LU1280957306.USD","IE00BK4W5M84.HKD","IE0034235188.USD","LU1721428933.USD","LU2100268510.USD","IE00BMPRXQ63.HKD","LU2087621335.USD","TRFK","LU0077335932.USD","LU0198837287.USD","NVYY","LU2361044949.HKD","LU2125154778.USD","LU2756315664.SGD","SNVD.UK","LU1868836914.USD","LU0788109477.HKD","LU1861215975.USD","LU2089284900.SGD","LU1861127337.USD","LU2463028550.USD","LU1232071149.USD","IE0004091025.USD","LU2047632596.USD","HK0000304797.USD","IE000YTNTUN2.SGD","TEK","IE00BKVL7J92.USD","LU1400636491.USD","NVDY","LU2250418816.HKD","SG9999014880.SGD","LU2750360641.GBP","LU1244550221.USD","LU1923622291.USD","SOXY","LU2954938101.SGD","LU2746668461.USD","LU2471134796.USD","07788","NVDG","LU2148611432.USD","LU2168563687.JPY","LU2506951792.HKD","NVII","LU2420271590.USD","LU2237957811.SGD","LU0820561818.USD","LU1868836591.USD","SG9999002224.SGD","LU0210536198.USD","NULC","LU1069344957.HKD","IE000KEQY171.SGD","IE00BWXC8680.SGD","IE0034235303.USD","LU0985320562.USD","LU2602419157.SGD","EFIV","LU0251132253.USD","LU0138981039.USD","LU0238689110.USD","SMH","LU0070217475.USD","LU0170899867.USD","LU0417517546.SGD","LU2592432038.USD","LU0708995401.HKD","LU1202635105.USD","ESUM","LU2083900584.USD","IE00BMPRXR70.SGD","IE0005OL40V9.USD","LU0308772762.SGD","ROM","SGXZ99366536.SGD","BK4614","LU1066053197.SGD","LU0683600562.USD","LU0096364046.USD","LU1821325948.USD","LU2023250330.USD","LU2237443465.HKD","LU0061475181.USD","LU1951200564.SGD","LU2237957902.USD","HK0000320223.HKD","LU2361045086.USD","SPTE","IE00B4YYXB79.USD","IE00BJLML261.HKD","LU1551013425.SGD","SG9999018857.SGD","LU2290526834.HKD","LU1127390331.HKD","LU2896262040.SGD","IE00BJJMRY28.SGD","HK0000914660.USD","IE000ITXATA3.USD","LU2552382215.SGD","IE00BFSS7M15.SGD","LU0107464264.USD","LU0889565833.HKD","LU2125909759.SGD","GB00BDT5M118.USD","LU2023251221.USD","LU2272731865.HKD","XLK","LU1839511570.USD","LU1674673428.USD","LU1116320737.USD","LU1064131342.USD","IE00BZ1G4Q59.USD","IE00BFSS8Q28.SGD","IE0004445239.USD","IETC","LU0786609619.USD","LU2271345857.HKD","LU2381873111.SGD","LU0345770993.USD","IE00BD6J9T35.USD","ILDR","LU2430703178.SGD","LU1935043023.USD","SG9999015978.USD","LU1153585028.USD","NVDD","LU0345769128.USD","LU2462591277.SGD","SG9999002232.USD","LU0823421333.USD","LU2237443382.USD","LU0965509101.SGD","LU0965508806.USD","LU2168564149.EUR","LU2487616109.SGD","LU2264538146.SGD","SG9999004303.SGD","VT","NVDA","LU1496350171.SGD","LU2552382132.HKD","LU0342679015.USD","LU0823414478.USD","BK4585","BK4605","LU0225283273.USD","LU1934455194.USD","BK4529","LU1804176565.USD","NVDW","BK4579","ARTY","LU0187121727.USD","SG9999015945.SGD","BK4202","LU1084165304.USD","LU2322448791.USD","LU0354030511.USD","LU2473716301.USD","IE000Q6AESB8.SGD","LU2125154935.USD","LU0724617625.USD","LU1815333072.USD","METV","LU1989772840.SGD","LU0476273544.USD","LU1261432733.SGD","WISE","USXF","LU0106261372.USD","LU0868494708.USD","LU2106854487.HKD","LU0266013472.USD","LU0823414551.USD","IE000W1ABFV2.USD","IE00BN29S564.USD","LU2168564222.USD","LU0708994859.HKD","LU1400636657.SGD","LU1323610961.USD","LU2237443549.SGD","BK4532","LU1645745479.HKD","SG9999015358.SGD","LU1992135399.USD","LU0353189763.USD","AIPI","IE00B3S45H60.SGD","BK4139","FAI","LU1691799644.USD","LU2211815571.USD","LU1989764664.SGD","LU1852331112.SGD","LU0942090050.USD","IE00B19Z9505.USD","LU2213496289.HKD","LU2168564495.EUR","LU2237443978.SGD","LU2430703095.HKD","BK4503","LU1935042215.USD","IE00B5949003.HKD","IE00BKDWB100.SGD","LU1629891620.HKD","LU2244417387.USD","LU0267386448.USD","IE0009356076.USD","SG9999014898.SGD","IE00BQXX3C00.GBP","LU1989772923.USD","LU2417539215.USD","IE00BMPRXN33.USD","LU2065171402.SGD","IE0001KFT4U8.USD","LU1923622614.USD","AGOX","HK0000304805.HKD","LU0211327993.USD","LU1934455863.HKD","BK4581","LU1267930573.SGD","LU1116320901.HKD","AIFD","IE00B1XK9C88.USD","BK4612","LU1244550577.SGD","LU1316542783.SGD","LU0174119429.USD","BK4592","NVDX","LU1935043536.SGD","LU1989764748.USD","IE00BJTD4V19.USD","LU2065170008.USD","LU1670756490.USD","LU1035775433.USD","LU1720051017.SGD","LU0061474705.USD","LU2191332357.HKD","LU0057025933.USD","LU1242518931.SGD","LU0964807845.USD","LU1623119135.USD","LU0323239441.USD","IE00BDCRKT87.USD","LU0133085943.USD","LU1429558221.USD","LU0823421416.USD","LU2092627202.USD","LU0097036916.USD","LU0310800379.SGD","LU1242518857.USD","BK4554","SOXX","LU2413666426.HKD","LU0072462426.USD","LU2361044865.SGD","LU0234572021.USD","JGRO","BK4587","LU0347712357.USD","LU2236285917.USD","LU2458330243.SGD","LFGY","LU0234570918.USD","LU1791710400.SGD","IE00B775H168.HKD","NVDS","LU1880398554.USD","LU2931357623.SGD","LU2054465674.USD","LU2272731600.USD","SGXZ51526630.SGD","LU1712237335.SGD","LU0096362180.USD","LU2860962120.EUR","LU0528227936.USD","LU0787776722.HKD","LU0109391861.USD","LU2357305700.SGD","LU2543165471.USD","HK0000306685.HKD","LU1718418525.SGD","LU1267930730.SGD","LU0265550946.USD","LU0640476718.USD","LU0354030438.USD","LU0965509283.SGD","07388","IE00B1BXHZ80.USD","LU0211328371.USD","LU1267930490.SGD","LU0215105999.USD","LU0203201768.USD","LU2413666699.HKD","SG9999015952.SGD","LU0672654240.SGD","LU1868836757.USD","SGXZ81514606.USD","USD","LU0203202063.USD","LU0444971666.USD","LU2505996681.GBP","LU2461242641.AUD","SMHX","LU0390134368.USD","CHAT","IE00B4JS1V06.HKD","LU0079474960.USD","BK4567","LU2452424414.USD","LU2237438978.USD","LU0348723411.USD","LU0353189680.USD","LU2097344431.USD","LU0265550359.USD","LU2357125470.USD","LU2552382058.USD","SG9999015986.USD","LU0061474960.USD","LU0256863811.USD","IE00B19Z8W00.USD","LU2111349929.HKD","LU2237443895.HKD","SGXZ31699556.SGD","LU0472753341.HKD","LU1037948541.HKD","SG9999014559.SGD","LU0069063385.USD","LU1435385759.SGD","LU0689472784.USD","LU2294711713.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136201644","title":"Silo Pharma 开展稳健性研究，评估 SPC-15 设备性能与制剂 30 天稳定性","url":"https://stock-news.laohu8.com/highlight/detail?id=1136201644","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136201644?lang=zh_cn&edition=full","pubTime":"2026-06-30 04:18","pubTimestamp":1782764295,"startTime":"0","endTime":"0","summary":"Silo Pharma 已启动一项稳健性研究，旨在全面评估其 SPC-15 设备在长达 30 天周期内的性能表现，并同时检验相关制剂的稳定性。该研究对于验证设备与药物配方的长期可靠性与一致性至关重要。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SILO","BK4202","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101449389","title":"Silo Pharma公布SPC-15创伤后应激障碍治疗药物稳定性数据积极，推动项目迈向首次人体临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1101449389","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101449389?lang=zh_cn&edition=full","pubTime":"2026-06-23 20:18","pubTimestamp":1782217096,"startTime":"0","endTime":"0","summary":"Silo Pharma公司宣布，其用于治疗创伤后应激障碍的候选药物SPC-15取得了积极的稳定性研究数据。这一关键进展标志着该药物开发项目向前迈出了坚实一步，正稳步推进至首次人体临床试验阶段。稳定性数据的成功，为后续临床研究的顺利开展奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SILO","BK4139","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117737017","title":"Silo Pharma旗下Demerx NB获FDA新药临床试验批准 诺伊波加因靶向酒精使用障碍治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1117737017","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117737017?lang=zh_cn&edition=full","pubTime":"2026-04-29 21:09","pubTimestamp":1777468162,"startTime":"0","endTime":"0","summary":"生物制药公司Silo Pharma Inc.宣布，其研发的Demerx NB新药已获得美国食品药品监督管理局（FDA）的新药临床试验（IND）批准。该药物以诺伊波加因（Noribogaine）为核心活性成分，旨在开发用于治疗酒精使用障碍（AUD）的新型疗法。\n此次IND获批标志着该候选药物正式获准进入人体临床研究阶段，为推进其治疗酒精依赖的潜力迈出关键一步。公司表示将按计划开展后续临床试验，以评估Demerx NB的安全性与有效性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4202","SILO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516580686","title":"Silo Pharma, Inc.盘中异动 股价大跌5.46%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516580686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516580686?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:52","pubTimestamp":1741017146,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时52分，Silo Pharma, Inc.股票出现异动，股价大幅跳水5.46%。截至发稿，该股报1.28美元/股，成交量2.1069万股，换手率0.47%，振幅4.43%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235227989a244e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235227989a244e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNS","BK4139","SILO","BK4202","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514438101","title":"Silo Pharma, Inc.盘中异动 股价大跌5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514438101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514438101?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:44","pubTimestamp":1740671073,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时44分，Silo Pharma, Inc.股票出现异动，股价大幅跳水5.67%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227234433abdf8164&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227234433abdf8164&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SILO","BK4135","CNS","BK4202","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514086930","title":"Silo Pharma, Inc.盘中异动 快速上涨5.40%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514086930","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514086930?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:30","pubTimestamp":1740594617,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时30分，Silo Pharma, Inc.股票出现波动，股价急速拉升5.40%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022702301896317b61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022702301896317b61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNS","BK4202","BK4139","SILO","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514604186","title":"Silo Pharma, Inc.盘中异动 急速拉升5.56%报1.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514604186","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514604186?lang=zh_cn&edition=full","pubTime":"2025-02-26 04:58","pubTimestamp":1740517098,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日04时58分，Silo Pharma, Inc.股票出现异动，股价急速拉升5.56%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260458189892928d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260458189892928d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SILO","BK4135","BK4202","CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513727576","title":"Silo Pharma, Inc.盘中异动 早盘股价大跌5.19%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513727576?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:48","pubTimestamp":1740408534,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时48分，Silo Pharma, Inc.股票出现异动，股价急速下跌5.19%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242248549890fa1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242248549890fa1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4135","SILO","CNS","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513153612","title":"Silo Pharma, Inc.盘中异动 下午盘急速下跌5.03%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513153612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513153612?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:02","pubTimestamp":1740160928,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时02分，Silo Pharma, Inc.股票出现波动，股价急速跳水5.03%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222020209962baaa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222020209962baaa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4202","SILO","BK4139","CNS","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512806564","title":"Silo Pharma, Inc.盘中异动 快速拉升5.00%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512806564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512806564?lang=zh_cn&edition=full","pubTime":"2025-02-20 01:35","pubTimestamp":1739986535,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日01时35分，Silo Pharma, Inc.股票出现波动，股价快速拉升5.00%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200135369628eb12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200135369628eb12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4202","BK4139","CNS","SILO","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510684380","title":"Silo Pharma, Inc.盘中异动 早盘大幅下跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510684380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510684380?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:43","pubTimestamp":1739285014,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时43分，Silo Pharma, Inc.股票出现异动，股价急速下跌5.19%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.36%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224334961f4a0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224334961f4a0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNS","OCEA","SILO","BK4202","BK4139","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509272485","title":"Silo Pharma, Inc.盘中异动 早盘快速拉升5.68%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509272485","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509272485?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:42","pubTimestamp":1738852920,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时42分，Silo Pharma, Inc.股票出现波动，股价快速上涨5.68%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206224201a23bd0d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206224201a23bd0d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNS","BK4139","SILO","BK4202","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508572594","title":"Silo Pharma, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508572594","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508572594?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:31","pubTimestamp":1738679489,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时31分，Silo Pharma, Inc.股票出现异动，股价大幅下挫5.02%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042231299617d782&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042231299617d782&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SILO","BK4139","BK4135","CNS","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508418381","title":"Silo Pharma, Inc.盘中异动 大幅上涨11.19%报1.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508418381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508418381?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:35","pubTimestamp":1738593321,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时35分，Silo Pharma, Inc.股票出现波动，股价大幅上涨11.19%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223521abc107f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223521abc107f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4135","CNS","BK4202","SILO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508696042","title":"Silo Pharma, Inc.盘中异动 大幅跳水5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508696042","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508696042?lang=zh_cn&edition=full","pubTime":"2025-02-01 00:55","pubTimestamp":1738342510,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日00时55分，Silo Pharma, Inc.股票出现异动，股价大幅跳水5.46%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.56%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020100551098777086&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020100551098777086&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SILO","BK4139","BK4135","BK4202","CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506454586","title":"Silo Pharma, Inc.盘中异动 下午盘大幅下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506454586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506454586?lang=zh_cn&edition=full","pubTime":"2025-01-28 02:39","pubTimestamp":1738003147,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日02时39分，Silo Pharma, Inc.股票出现波动，股价急速跳水5.07%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012802390796125e17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012802390796125e17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SILO","BK4135","BK4139","CNS","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505477864","title":"Silo Pharma, Inc.盘中异动 股价大涨5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505477864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505477864?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:13","pubTimestamp":1737731614,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日23时13分，Silo Pharma, Inc.股票出现波动，股价大幅上涨5.61%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.64%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124231335a22e63ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124231335a22e63ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNS","BK4202","BK4139","SILO","BK4135"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.silopharma.com","stockEarnings":[{"period":"1week","weight":-0.2416},{"period":"1month","weight":-0.3859},{"period":"3month","weight":-0.7601},{"period":"6month","weight":-0.8677},{"period":"1year","weight":-0.8654},{"period":"ytd","weight":-0.7784}],"compareEarnings":[{"period":"1week","weight":-0.0149},{"period":"1month","weight":0.0063},{"period":"3month","weight":0.0243},{"period":"6month","weight":0.0777},{"period":"1year","weight":0.1537},{"period":"ytd","weight":0.124}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Silo Pharma, Inc.于2010年7月13日在纽约州注册成立。2013年1月24日，公司将其注册地从纽约州改为特拉华州。2023年12月19日，该公司将其注册州从特拉华州改为内华达州。该公司是一家处于开发阶段的生物制药和加密货币公司，专注于开发针对创伤后应激障碍、应激性焦虑症、纤维肌痛和中枢神经系统疾病等未满足需求的新型疗法。其主要项目SPC-15是一种用于治疗创伤后应激障碍和应激性焦虑症的鼻内候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.152367},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.066329},{"month":3,"riseRate":0.333333,"avgChangeRate":0.008428},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.080378},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.077056},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.06968},{"month":7,"riseRate":0.666667,"avgChangeRate":0.150388},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.191166},{"month":9,"riseRate":0.5,"avgChangeRate":6.654054},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.174654},{"month":11,"riseRate":0.333333,"avgChangeRate":0.075379},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.093022}],"exchange":"NASDAQ","name":"SILO PHARMA INC.","nameEN":"SILO PHARMA INC."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SILO PHARMA INC.(SILO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供SILO PHARMA INC.(SILO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"SILO PHARMA INC.,SILO,SILO PHARMA INC.股票,SILO PHARMA INC.股票老虎,SILO PHARMA INC.股票老虎国际,SILO PHARMA INC.行情,SILO PHARMA INC.股票行情,SILO PHARMA INC.股价,SILO PHARMA INC.股市,SILO PHARMA INC.股票价格,SILO PHARMA INC.股票交易,SILO PHARMA INC.股票购买,SILO PHARMA INC.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SILO PHARMA INC.(SILO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供SILO PHARMA INC.(SILO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}